Grainne M. O’Kane

8.7k total citations
121 papers, 1.3k citations indexed

About

Grainne M. O’Kane is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Grainne M. O’Kane has authored 121 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 47 papers in Cancer Research and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Grainne M. O’Kane's work include Cancer Genomics and Diagnostics (43 papers), Pancreatic and Hepatic Oncology Research (40 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers). Grainne M. O’Kane is often cited by papers focused on Cancer Genomics and Diagnostics (43 papers), Pancreatic and Hepatic Oncology Research (40 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers). Grainne M. O’Kane collaborates with scholars based in Canada, Ireland and United States. Grainne M. O’Kane's co-authors include Steven Gallinger, Natasha B. Leighl, Jennifer J. Knox, T. Barnes, Robert C. Grant, Geoffrey Liu, Faiyaz Notta, Frances A. Shepherd, Ming‐Sound Tsao and Penelope A. Bradbury and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer Research.

In The Last Decade

Grainne M. O’Kane

111 papers receiving 1.3k citations

Peers

Grainne M. O’Kane
David Watkins United Kingdom
Gary V. Burton United States
Gun Min Kim South Korea
Yan Song United States
Yosuke Shimizu Japan
Lily Lai United States
Susan B. Kesmodel United States
J.-Y. Douillard France
Ziad Bakouny United States
Som D. Mukherjee Canada
David Watkins United Kingdom
Grainne M. O’Kane
Citations per year, relative to Grainne M. O’Kane Grainne M. O’Kane (= 1×) peers David Watkins

Countries citing papers authored by Grainne M. O’Kane

Since Specialization
Citations

This map shows the geographic impact of Grainne M. O’Kane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grainne M. O’Kane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grainne M. O’Kane more than expected).

Fields of papers citing papers by Grainne M. O’Kane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grainne M. O’Kane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grainne M. O’Kane. The network helps show where Grainne M. O’Kane may publish in the future.

Co-authorship network of co-authors of Grainne M. O’Kane

This figure shows the co-authorship network connecting the top 25 collaborators of Grainne M. O’Kane. A scholar is included among the top collaborators of Grainne M. O’Kane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grainne M. O’Kane. Grainne M. O’Kane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ladak, Farah, Woo Jin Choi, Arndt Vogel, et al.. (2025). Liver transplantation for HCC with macrovascular invasion: A systematic review and meta-analysis of observational studies. JHEP Reports. 8(1). 101566–101566. 1 indexed citations
2.
Li, Zhihao, Leonardo Centonze, Tommy Ivanics, et al.. (2025). Validation of the Toronto recurrence inference using machine-learning for post-transplant hepatocellular carcinoma model. Communications Medicine. 5(1). 284–284. 2 indexed citations
3.
Bartels, Marius, Benoist Chibaudel, Rodrigo Dienstmann, et al.. (2024). Evolving and Improving the Sustainability of Molecular Tumor Boards: The Value and Challenges. Cancers. 16(16). 2888–2888. 1 indexed citations
4.
Narayan, Raja R., Marc G. Besselink, Casper H.J. van Eijck, et al.. (2024). Chemotherapy switch for localized pancreatic cancer: a systematic review and meta-analysis. British journal of surgery. 111(10). 3 indexed citations
5.
O’Kane, Grainne M., Jennifer L. Spratlin, D-Y. Oh, et al.. (2024). 44P BOLD-100-001: A phase II study of BOLD-100 in combination with FOLFOX in advanced mCRC patients that have failed at least two prior lines of therapy. Annals of Oncology. 35. S22–S22. 1 indexed citations
6.
7.
Knox, Jennifer J., Elizabeth M. Jaffee, Grainne M. O’Kane, et al.. (2024). Early results of the PASS-01 trial: Pancreatic adenocarcinoma signature stratification for treatment-01.. Journal of Clinical Oncology. 42(17_suppl). LBA4004–LBA4004. 6 indexed citations
8.
Ubhi, Tajinder, Olga Zaslaver, Andrew T. Quaile, et al.. (2024). Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells. Nature Cancer. 5(6). 895–915. 12 indexed citations
9.
O’Kane, Grainne M., Do‐Youn Oh, Jennifer L. Spratlin, et al.. (2024). A phase 2 study of BOLD-100 in combination with FOLFOX chemotherapy in patients with pretreated advanced biliary tract cancer: Efficacy and safety analysis (BOLD-100-001).. Journal of Clinical Oncology. 42(16_suppl). 4115–4115. 2 indexed citations
10.
Li, Zhihao, Daniel Aliseda, Owen Jones, et al.. (2024). Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival data. JHEP Reports. 7(3). 101290–101290. 3 indexed citations
11.
Li, Zhihao, Leonardo Centonze, Woo Jin Choi, et al.. (2024). Analysis of treatment benefits and prognostic factors for posttransplant HCC recurrence in a large Euro-American-Asian cohort. Liver Transplantation. 31(4). 450–463. 1 indexed citations
12.
Rajendran, Luckshi, Zhihao Li, Woo Jin Choi, et al.. (2024). Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Transplantation. 109(4). 681–690. 4 indexed citations
13.
Romero, Joan Miguel, Emma Titmuss, Yifan Wang, et al.. (2023). Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers. npj Precision Oncology. 7(1). 73–73. 8 indexed citations
14.
Jang, Gun Ho, Robert C. Grant, Faiyaz Notta, et al.. (2023). hENT1 as a Predictive Biomarker in PDAC—Response. Clinical Cancer Research. 29(15). 2945–2948.
15.
O’Kane, Grainne M., Warren Mason, Pavlina Spiliopoulou, et al.. (2023). Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma. Molecular Cancer Therapeutics. 23(3). 394–399. 6 indexed citations
16.
O’Kane, Grainne M. & Maeve A. Lowery. (2022). Moving the Needle on Precision Medicine in Pancreatic Cancer. Journal of Clinical Oncology. 40(24). 2693–2705. 24 indexed citations
17.
O’Kane, Grainne M., Geoffrey Liu, Tracy Stockley, et al.. (2019). The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance. Lung Cancer. 131. 86–89. 14 indexed citations
18.
O’Kane, Grainne M., et al.. (2018). Systemic Therapy of Lung Cancer CNS Metastases Using Molecularly Targeted Agents and Immune Checkpoint Inhibitors. CNS Drugs. 32(6). 527–542. 10 indexed citations
19.
O’Kane, Grainne M., Ashton A. Connor, & Steven Gallinger. (2017). Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer. Trends in Molecular Medicine. 23(12). 1121–1137. 42 indexed citations
20.
O’Kane, Grainne M., et al.. (1993). Intensive care in an Irish district general hospital--a three year review.. PubMed. 86(1). 10–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Watkins Breakdown of academic impact, for papers by Gary V. Burton Breakdown of academic impact, for papers by Gun Min Kim Breakdown of academic impact, for papers by Yan Song Breakdown of academic impact, for papers by Yosuke Shimizu Breakdown of academic impact, for papers by Lily Lai Breakdown of academic impact, for papers by Susan B. Kesmodel Breakdown of academic impact, for papers by J.-Y. Douillard Breakdown of academic impact, for papers by Ziad Bakouny Breakdown of academic impact, for papers by Som D. Mukherjee
Rankless by CCL
2026